The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.

Pharmacology, biochemistry, and behavior 20120701

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

Brain, behavior, and immunity 20111101

Could monoamine oxidase inhibitors promote asystole in electroconvulsive therapy patients?

The journal of ECT 20110901

Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1).

PLoS pathogens 20110801

The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.

The Journal of neuropsychiatry and clinical neurosciences 20110101

Phenelzine-induced myocardial injury: a case report.

Journal of medical toxicology : official journal of the American College of Medical Toxicology 20101201

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity.

Journal of neurochemistry 20100901

A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.

Archives of general psychiatry 20100301

The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics.

Pharmacology, biochemistry, and behavior 20100201

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Nature chemical biology 20091001

Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model.

The American journal of pathology 20091001

Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.

Brain research 20090908

Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area.

The international journal of neuropsychopharmacology 20090501

Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501

Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes.

Molecular pharmacology 20090501

[Irreversible, non-selective monoamine oxidase inhibitors].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090416

Protective effect of tamoxifen, a synthetic non-steroidal antiestrogen, on phenelzine and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.

Research communications in molecular pathology and pharmacology 20090101

Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.

Brain research 20081031

Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report.

Bipolar disorders 20080701

Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.

Pharmacological research 20080601

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

Brain research 20080523

Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20080516

Modulation of dopaminergic neurotransmission in rat striatum upon in vitro and in vivo diclofenac treatment.

Journal of neurochemistry 20080401

Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Neurochemical research 20080301

Acute myocarditis after massive phenelzine overdose.

European journal of clinical pharmacology 20071101

The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.

Behavioural pharmacology 20071101

Not all monoamine oxidase inhibitors are created equal.

Journal of the American Geriatrics Society 20071101

Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.

International clinical psychopharmacology 20070901

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Journal of psychiatry & neuroscience : JPN 20070901

Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.

The Journal of clinical psychiatry 20070801

Treating DSM-IV depression with atypical features.

The Journal of clinical psychiatry 20070401

Successful use of phenelzine in treatment-resistant panic disorder.

The Journal of clinical psychiatry 20070201

Evolution of the clock from yeast to man by period-doubling folds in the cellular oscillator.

Cold Spring Harbor symposia on quantitative biology 20070101

Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.

Anesthesia and analgesia 20061201

Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine.

Brain research 20061129

Increased nicotine self-administration following prenatal exposure in female rats.

Pharmacology, biochemistry, and behavior 20061101

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

Journal of clinical psychopharmacology 20061001

Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum.

Toxicology 20060501

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.

CNS spectrums 20060501

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

CNS spectrums 20060501

An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid.

British journal of clinical pharmacology 20060501

Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.

The Annals of pharmacotherapy 20060301

Treatment of depression with atypical features: a meta-analytic approach.

Psychiatry research 20060130

Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.

Neuroscience 20060101

Screening antidepressants in the chick separation-stress paradigm.

Psychopharmacology 20050801

Inhibition of monoamine oxidase-A activity in rat brain by synthetic hydrazines: structure-activity relationship (SAR).

Journal of enzyme inhibition and medicinal chemistry 20050601

Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.

Endocrinology 20050301

Validity of sudden gains in acute phase treatment of depression.

Journal of consulting and clinical psychology 20050201

Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram.

BMC pharmacology 20050101

Shy-Drager syndrome: multisystem atrophy with comorbid depression.

Psychosomatics 20050101

In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.

Neuroscience 20050101

Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.

The Journal of clinical psychiatry 20041101

Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus.

Biochemical pharmacology 20041015

Modafinil augmentation of phenelzine for residual fatigue in dysthymia.

The American journal of psychiatry 20040901

Coadministration of phenelzine and methylphenidate for treatment-resistant depression.

The Annals of pharmacotherapy 20040301

Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells.

Neurochemical research 20031201

Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants.

Molecular psychiatry 20031101

[Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].

Nederlands tijdschrift voor geneeskunde 20031004

Comparing depression treatments.

The American journal of psychiatry 20030601

Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.

Journal of sleep research 20030301

Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine.

European journal of pharmacology 20030117

Phenelzine efficacy in refractory social anxiety disorder: a case series.

Nordic journal of psychiatry 20030101

Pharmacological treatment of social anxiety disorder: a meta-analysis.

Depression and anxiety 20030101

Phenelzine treatment increases transcription factor AP-2 levels in rat brain.

BMC pharmacology 20030101

Selective mutism: a review of the concept and treatment.

The Israel Medical Association journal : IMAJ 20021201

Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.

The American journal of psychiatry 20020801

Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.

Journal of psychiatry & neuroscience : JPN 20020501

Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.

Biochemical pharmacology 20020101

The management of panic disorder.

The Journal of clinical psychiatry 20020101

Effect of chronic phenelzine treatment on REM sleep: report of three patients.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101

Synthesis of N-propargylphenelzine and analogues as neuroprotective agents.

Bioorganic & medicinal chemistry letters 20011022

Effects of the antidepressant/antipanic drug phenelzine on alanine and alanine transaminase in rat brain.

Cellular and molecular neurobiology 20010801

Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression.

Molecular psychiatry 20010701

The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat.

Pflugers Archiv : European journal of physiology 20010701

Application of capillary electrophoresis with laser-induced fluorescence detection to the determination of biogenic amines and amino acids in brain microdialysate and homogenate samples.

Journal of chromatography. A 20010420

Animal models for the study of antidepressant activity.

Brain research. Brain research protocols 20010401

Sleep and sleep electroencephalogram in depressed patients treated with phenelzine.

Archives of general psychiatry 20010301

Social phobia: etiology, neurobiology, and treatment.

The Journal of clinical psychiatry 20010101

Current status of psychotherapeutic interventions for social phobia.

The Journal of clinical psychiatry 20010101

Treatment of social phobia with antidepressants.

The Journal of clinical psychiatry 20010101

Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression.

Depression and anxiety 20010101

Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat Substantia nigra and prefrontal cortex induced by psychotropic drugs.

Neuropsychobiology 20010101

Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.

The Journal of neuroscience : the official journal of the Society for Neuroscience 19991201

[Clinical case of the month. Mental confusion due to the administration of tramadol in a patient treated with MOAI].

Revue medicale de Liege 19991201

Seizures in a diabetic patient on monoamine oxidase inhibitors.

The American journal of emergency medicine 19990101

Phenelzine-induced sexual dysfunction treated with sildenafil.

Journal of sex & marital therapy 19990101

Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.

Neurology 19980701

Stroke resulting from a rapid switch from phenelzine to tranylcypromine.

The Journal of clinical psychiatry 19980701

Serotonin syndrome secondary to phenelzine-venlafaxine interaction.

Pharmacotherapy 19980101

Seizure resulting from a venlafaxine overdose.

The Annals of pharmacotherapy 19970201

Phenelzine-induced fulminant hepatic failure.

Annals of internal medicine 19960401

Serotonin syndrome induced by administration of venlafaxine and phenelzine.

The Annals of pharmacotherapy 19960101

Extreme suicidality following serotonin syndrome.

The British journal of psychiatry : the journal of mental science 19950901

Phenelzine and venlafaxine interaction.

The American journal of psychiatry 19950901

Monoamine oxidase inhibitors and sleep movements.

The American journal of psychiatry 19940501

Dose-related visual hallucinations in macular degeneration patients receiving phenelzine.

The American journal of psychiatry 19940301

Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer.

Journal of clinical psychopharmacology 19940201

Depression after cyproheptadine: MAO treatment.

Biological psychiatry 19920601

Possible interaction between an MAOI and 'ecstasy'.

The American journal of psychiatry 19920301

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications.

Brain research 19920214

Abuse of monoamine oxidase inhibitors.

The American journal of drug and alcohol abuse 19920101

Action of hydrazine drugs in tumor-free and 1,2-dimethylhydrazine-treated male rats.

Oncology research 19920101

Phenelzine associated peripheral neuropathy--clinical and electrophysiologic findings.

Australian and New Zealand journal of medicine 19910601

Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study.

The Journal of clinical psychiatry 19910601

Delayed excitatory reaction following interaction of cocaine and monoamine oxidase inhibitor (phenelzine).

British journal of anaesthesia 19910401

Drug interaction.

Hospital & community psychiatry 19900701

Case of delirium secondary to phenelzine/L-tryptophan combination.

The Journal of clinical psychiatry 19900701

Adverse consequences of fluoxetine-MAOI combination therapy.

The Journal of clinical psychiatry 19900601

Acute dystonic reaction induced by a monoamine oxidase inhibitor.

Journal of clinical psychopharmacology 19900401

MAOI-induced hypersomnia in patients with bulimia.

The American journal of psychiatry 19890801

Phenelzine-associated inappropriate ADH secretion.

Journal of clinical psychopharmacology 19890801

The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients.

International psychogeriatrics 19890101

Common side effects associated with monoamine oxidase inhibitors.

Progress in neuro-psychopharmacology & biological psychiatry 19890101

Mania associated with high percentage of inhibition of monoamine oxidase.

The American journal of psychiatry 19890101

Bradycardia induced by an interaction between phenelzine and beta blockers.

Psychosomatics 19890101

Severe daytime somnolence in patients treated with an MAOI.

The American journal of psychiatry 19881201

Drug-induced catatonia.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 19881001

Phenelzine vs placebo in 50 patients with bulimia.

Archives of general psychiatry 19880501

Sexual dysfunction related to alprazolam treatment of social phobia.

The American journal of psychiatry 19880401

Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Journal of neural transmission 19880101

A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.

Journal of clinical psychopharmacology 19871201

Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment.

Clinical neuropharmacology 19871201

Possible toxic interaction between cyproheptadine and phenelzine.

The American journal of psychiatry 19870901

Myoclonus and episodic delirium associated with phenelzine: a case report.

The Journal of clinical psychiatry 19870801

The Newcastle chronic depression study: results of a treatment regime.

International clinical psychopharmacology 19870701

Spontaneous remission of MAOI-induced anorgasmia.

The American journal of psychiatry 19870601

Hypomania related to phenelzine and isoetharine interaction in one patient.

The Journal of clinical psychiatry 19870401

Anorgasmia caused by an MAOI.

The American journal of psychiatry 19870401

Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.

The Journal of nervous and mental disease 19870201

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

Biological psychiatry 19861001

Phenelzine induced grand mal seizure.

The British journal of clinical practice 19860401

Parkinsonism induced by a monoamine oxidase inhibitor.

Postgraduate medical journal 19860301

Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.

The Journal of clinical psychiatry 19860201

Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.

The American journal of psychiatry 19851201

Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 19851001

Phenelzine-induced hypomania: effect of verapamil.

Biological psychiatry 19850901

Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.

The American journal of psychiatry 19850401

Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.

Journal of clinical psychopharmacology 19850201

Acute psychosis following phenelzine discontinuation.

Journal of clinical psychopharmacology 19850201

Possible interaction between pheneizine and amantadine.

Archives of general psychiatry 19840701

Epilepsy as an adverse reaction to combined therapy of MAOIs and tricyclics.

Journal of the Royal Society of Medicine 19840401

Case report of a toxic reaction from a combination of tryptophan and phenelzine.

The American journal of psychiatry 19840201

The treatment of phenelzine-induced hypotension with salt tablets: case report.

The Journal of clinical psychiatry 19840201

Parkinsonian side effects induced by a monoamine oxidase inhibitor.

The American journal of psychiatry 19840101

MAOIs, anorgasmia, and weight gain.

The American journal of psychiatry 19830901

Adverse reactions to abrupt discontinuation of phenelzine.

Journal of clinical psychopharmacology 19830601

Pure motor hemiplegia associated with phenelzine use.

IMJ. Illinois medical journal 19830401

Anorgasmia caused by MAOIs.

The American journal of psychiatry 19830401

Interaction of phenelzine and sulfisoxazole.

The American journal of psychiatry 19830201

More cases of anorgasmia after MAOI treatment.

The American journal of psychiatry 19830201

Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction.

Lancet (London, England) 19820821

Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.

The Journal of clinical psychiatry 19820501

Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients.

Archives of general psychiatry 19820501

MAOI-induced rapid cycling bipolar affective disorder in an adolescent.

The American journal of psychiatry 19810501

Ejaculatory impairment from both phenelzine and imipramine, with tinnitus from phenelzine.

Journal of clinical psychopharmacology 19810501

Angiosarcoma of liver associated with phenelzine.

British medical journal 19790623

Clinical consequences of polymorphic acetylation of basic drugs.

Clinical pharmacology and therapeutics 19770901

Pharmacological and biochemical studies with three metabolites of nomifensine.

Psychopharmacology 19770131

Tumorigenicity of beta-phenylethylhydrazine sulfate in mice.

Cancer research 19760301

Letter: Withdrawal symptoms after stopping phenelzine?

British medical journal 19740511

A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.

The British journal of psychiatry : the journal of mental science 19740301

The mechanism of the potentiating effect of antidepressant drugs on the protective influenc oe of diphenhydramine in experimental catatonia. The role of histamine.

Pharmacology 19740101

Adverse reactions to phenelzine: results of a nine-hospital depression study.

The Journal of clinical pharmacology and new drugs 19720101

Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.

The New England journal of medicine 19711028

Tricyclic antidepressants and monoamine oxidase inhibitors.

Archives of general psychiatry 19710601

Monoamine oxidase inhibitors and L-dopa.

British medical journal 19700815

Low serum pseudocholinesterase levels complicating treatment with phenelzine.

British medical journal 19690830

'Cold' cures and monoamine-oxidase inhibitors.

British medical journal 19690329

Hypertension from cold remedies.

British medical journal 19690329

Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat.

The Journal of pharmacology and experimental therapeutics 19670901

Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.

Proceedings of the Western Pharmacology Society 19660101